1. Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z.
   Salvatore Sciacchitano et al, 2018, Int J Mol Sci CrossRef
2. Galectin-3 in Atrial Fibrillation: Mechanisms and Therapeutic Implications
   Nicolas Clementy et al, 2018, IJMS CrossRef
3. Subclinical myocardial injury during vaso-occlusive crisis in pediatric sickle cell disease
   Reham Wagdy et al, 2018, Eur J Pediatr CrossRef
4. Circulating Galectin-3 and Atrial Fibrillation Recurrence after Catheter Ablation: A Meta-Analysis
   Guangping Zhang et al, 2019, Cardiovascular Therapeutics CrossRef
5. Elevated Platelet Galectin-3 and Rho-Associated Protein Kinase Activity Are Associated with Hemodialysis Arteriovenous Shunt Dysfunction among Subjects with Diabetes Mellitus
   Po-Wei Chen et al, 2019, BioMed Research International CrossRef
6. The Number of Liver Galectin-3 Positive Cells Is Dually Correlated with NAFLD Severity in Children
   Felipe Leite de Oliveira et al, 2019, IJMS CrossRef
7. Pleiotropic Effects of Modified Citrus Pectin
   Isaac Eliaz et al, 2019, Nutrients CrossRef
8. Calreticulin and Galectin-3 Opsonise Bacteria for Phagocytosis by Microglia
   Tom O. J. Cockram et al, 2019, Front. Immunol. CrossRef
9. Role of oxidative stress-related biomarkers in heart failure: galectin 3, α1-antitrypsin and LOX-1: new therapeutic perspective?
   Valter Lubrano et al, 2019, Mol Cell Biochem CrossRef
10. FOXD1 and Gal-3 Form a Positive Regulatory Loop to Regulate Lung Cancer Aggressiveness.
    Chien-Hsiu Li et al, 2019, Cancers (Basel) CrossRef
11. Galectin-3 as a Next-Generation Biomarker for Detecting Early Stage of Various Diseases
    Akira Hara et al, 2020, Biomolecules CrossRef
12. Non-classical role of Galectin-3 in cancer progression: translocation to nucleus by carbohydrate-recognition independent manner
    Seok-Jun Kim et al, 2020, BMB Rep. CrossRef
13. Glycosylation and raft endocytosis in cancer
    Ludger Johannes et al, 2020, Cancer Metastasis Rev CrossRef
14. Common Drug Pipelines for the Treatment of Diabetic Nephropathy and Hepatopathy: Can We Kill Two Birds with One Stone?
    Yoshio Sumida et al, 2020, IJMS CrossRef
15. Quinoline-Pyrazole Scaffold as a Novel Ligand of Galectin-3 and Suppressor of TREM2 Signaling
    Moustafa Gabr et al, 2020, ACS Med. Chem. Lett. CrossRef
16. Evaluation of serum galectin-3 levels at Alzheimer patients by stages: a preliminary report
    Tamer Yazar et al, 2020, Acta Neurol Belg CrossRef
17. Galectin-3 as a Therapeutic Target for NSAID-Induced Intestinal Ulcers
    Ah-Mee Park et al, 2020, Front. Immunol. CrossRef
18. Galectin-3: A Potential Prognostic and Diagnostic Marker for Heart Disease and Detection of Early Stage Pathology
    Akira Hara et al, 2020, Biomolecules CrossRef
19. Valid cardiac biochemical markers. Part II
    N. G. Gumanova et al, 2020, Cardiovasc Ther Prev CrossRef
20. Galectin-3 in Cardiovascular Diseases
    Valeria Blanda et al, 2020, IJMS CrossRef
21. The Extracellular Matrix-Derived Biomarkers for Diagnosis, Prognosis, and Personalized Therapy of Malignant Tumors
    Elena V. Petersen et al, 2020, Front. Oncol. CrossRef
22. Implications of Glycosylation in Alzheimer’s Disease
    Henriette Haukedal et al, 2021, Front. Neurosci. CrossRef
23. Inhibition of ATGL in adipose tissue ameliorates isoproterenol-induced cardiac remodeling by reducing adipose tissue inflammation
    Shingo Takahara et al, 2021, American Journal of Physiology-Heart and Circulatory Physiology CrossRef
24. Galectin-3 mediates cardiac remodeling caused by impaired glucose and lipid metabolism through inhibiting two pathways of activating Akt
    Zhen Sun et al, 2021, American Journal of Physiology-Heart and Circulatory Physiology CrossRef
25. Glycans and Glycan-Binding Proteins as Regulators and Potential Targets in Leukocyte Recruitment
    Franziska Krautter et al, 2021, Front. Cell Dev. Biol. CrossRef
26. New biomarkers of injury, inflammation and remodeling in the differential diagnosis of heart failure types
    E. K. Serezhina et al, 2021, Russ J Cardiol CrossRef
27. Reprogramming the tumor metastasis cascade by targeting galectin-driven networks
    Ramiro M. Perrotta et al, 2021 CrossRef
28. Review of Galectin-3 inhibitors in the treatment of nonalcoholic steatohepatitis
    Atef Al Attar et al, 2021, Expert Review of Clinical Pharmacology CrossRef
29. Activation of AMPK inhibits Galectin-3-induced pulmonary artery smooth muscle cells proliferation by upregulating hippo signaling effector YAP
    Qianqian Zhang et al, 2021, Mol Cell Biochem CrossRef
30. Disorders of carbohydrate-lipid metabolism and galectin-3 level as factors of liver fibrosis progression in chronic hepatitis C
    V. A. Kovalevа et al, 2021, Terapevticheskii arkhiv CrossRef
31. Galectin-3 Mediated Inflammatory Response Contributes to Neurological Recovery by QiShenYiQi in Subacute Stroke Model
    Yule Wang et al, 2021, Front. Pharmacol. CrossRef
32. Review of Diagnostic Biomarkers in Autoimmune Pancreatitis: Where Are We Now?
    Masataka Yokode et al, 2021, Diagnostics CrossRef
33. Galectin-3—A New Player of Kidney Damage or an Innocent Bystander in Children with a Single Kidney?
    Eryk Latoch et al, 2021, JCM CrossRef
34. Heart Failure and Diabetes Mellitus: Biomarkers in Risk Stratification and Prognostication
    Michael Lichtenauer et al, 2021, Applied Sciences CrossRef
35. The Antiviral Role of Galectins toward Influenza A Virus Infection—An Alternative Strategy for Influenza Therapy
    Chih-Yen Lin et al, 2021, Pharmaceuticals CrossRef
36. The Therapeutic Potential of Galectin-3 in the Treatment of Intrahepatic Cholangiocarcinoma Patients and Those Compromised With COVID-19
    Hao Li et al, 2021, Front. Mol. Biosci. CrossRef
37. Correlation between Biomarkers and Ischemic Stroke
    明敏 梁, 2021, ACM CrossRef
38. Mesenchymal stem cells ameliorate renal fibrosis by galectin-3/Akt/GSK3β/Snail signaling pathway in adenine-induced nephropathy rat
    Huajun Tang et al, 2021, Stem Cell Res Ther CrossRef
39. Analysis of the Correlation of Galectin-3 Concentration with the Measurements of Echocardiographic Parameters Assessing Left Atrial Remodeling and Function in Patients with Persistent Atrial Fibrillation
    Paweł Wałek et al, 2021, Biomolecules CrossRef
40. Anti-Cancer Potential of Afzelin towards AGS Gastric Cancer Cells.
    Iwona Radziejewska, 0 CrossRef
41. Physical Activity Attenuates the Obesity-Induced Dysregulated Expression of Brown Adipokines in Murine Interscapular Brown Adipose Tissue
    Takuya Sakurai et al, 2021, IJMS CrossRef
42. Circulating Galectin-3 Evaluation in Dogs With Cardiac and Non-cardiac Diseases
    Ga-Won Lee et al, 2021, Front. Vet. Sci. CrossRef
43. Microglia in Neuroinflammation and Neurodegeneration: From Understanding to Therapy
    Luca Muzio et al, 2021, Front. Neurosci. CrossRef
44. Combination Informatic and Experimental Approach for Selecting Scaffold Proteins for Development as Antibody Mimetics
    Tomoyuki Ito et al, 2021, Chem. Lett. CrossRef
45. Biomarkers Utility: At the Borderline between Cardiology and Neurology
    Adriana Ion et al, 2021, JCDD CrossRef
46. Emerging role of signal transducer and activator of transcription 3 (STAT3) in pituitary adenomas
    Cyndy Liu et al, 2021, Endocr J CrossRef
47. RNA-seq driven expression and enrichment analysis to investigate CVD genes with associated phenotypes among high-risk heart failure patients
    Zeeshan Ahmed et al, 2021, Hum Genomics CrossRef
48. “Multiomics” Approaches to Understand and Treat COVID-19: Mass Spectrometry and Next-Generation Sequencing
    Diane Appiasie et al, 2021, BioChem CrossRef
49. Expression of Immune Checkpoints in Malignant Tumors: Therapy Targets and Biomarkers for the Gastric Cancer Prognosis
    Danzan Mansorunov et al, 2021, Diagnostics CrossRef
50. Integrating RNA-Seq With GWAS Reveals a Novel SNP in Immune-Related HLA-DQB1 Gene Associated With Occupational Pulmonary Fibrosis Risk: A Multi-Stage Study
    Yan Zhou et al, 2022, Front. Immunol. CrossRef
51. Hepatic galectin-3 is associated with lipid droplet area in non-alcoholic steatohepatitis in a new swine model
    Luis V. Herrera-Marcos et al, 2022, Sci Rep CrossRef
52. Serum Level of Galectin-3 in Early Detection of Acute Pancreatitis
    Samaneh Porozan et al, 2021, Middle East J Dig Dis CrossRef
53. Review of Novel Potential Insulin Resistance Biomarkers in PCOS Patients—The Debate Is Still Open
    Jagoda Kruszewska et al, 2022, IJERPH CrossRef
54. Can galectin-3 be used to predict the severity of vasoocclusive crisis in patients with sickle cell anaemia?
    Mahmut Bakir Koyuncu et al, 2022, Med Sci Discov CrossRef
55. Metformin: Expanding the Scope of Application—Starting Earlier than Yesterday, Canceling Later
    Yulia A. Kononova et al, 2022, IJMS CrossRef
56. Integrated Analysis of DNA Repair Genes Identifies SLC6A1 as a New Marker for the Clinical Outcome of Patients with Colorectal Cancer
    Qian-qian Wang et al, 2022, Disease Markers CrossRef
57. Chronic kidney disease predictors in obese adolescents
    Katarzyna Mackowiak-Lewandowicz et al, 2022, Pediatr Nephrol CrossRef
58. Key Players of the Immunosuppressive Tumor Microenvironment and Emerging Therapeutic Strategies
    Kevin Park et al, 2022, Front. Cell Dev. Biol. CrossRef
59. Effects of liraglutide vs. lifestyle changes on soluble suppression of tumorigenesis-2 (sST2) and galectin-3 in obese subjects with prediabetes or type 2 diabetes after comparable weight loss
    Paola Simeone et al, 2022, Cardiovasc Diabetol CrossRef
60. Abnormal ECA-Binding Membrane Glycans and Galactosylated CAT and P4HB in Lesion Tissues as Potential Biomarkers for Hepatocellular Carcinoma Diagnosis
    Ying Kong et al, 2022, Front. Oncol. CrossRef
61. Inhibitory Immune Checkpoint Receptors and Ligands as Prognostic Biomarkers in COVID-19 Patients
    Mohammad A. Al-Mterin et al, 2022, Front. Immunol. CrossRef
62. Emerging Biomarkers for Early Detection of Chronic Kidney Disease
    Maja Mizdrak et al, 2022, JPM CrossRef
63. Small-Molecule Inhibitors Targeting Lipolysis in Human Adipocytes
    Gernot F. Grabner et al, 2022, J. Am. Chem. Soc. CrossRef
64. Frailty in Aging and the Search for the Optimal Biomarker: A Review
    Magdalena Sepúlveda et al, 2022, Biomedicines CrossRef
65. Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers
    Michela Chianca et al, 2022, Front. Cardiovasc. Med. CrossRef
66. Galectin-3 Involvement in Cognitive Processes for New Therapeutic Considerations
    Nataša R. Mijailović et al, 2022, Front. Cell. Neurosci. CrossRef
67. Photobiomodulation therapy's effects on cardiac fibrosis activation after experimental myocardial infarction
    Regiane dos S. Feliciano et al, 2022, Lasers Surg Med CrossRef
68. The Effect and Mechanism of External Use Ulcer Powder on Diabetic Mice
    Bingyang Wang et al, 2022 CrossRef
69. Identification of Monosaccharide Derivatives as Potent, Selective, and Orally Bioavailable Inhibitors of Human and Mouse Galectin-3
    Chunjian Liu et al, 2022, J. Med. Chem. CrossRef
70. From Classic to Modern Prognostic Biomarkers in Patients with Acute Myocardial Infarction
    Cristian Stătescu et al, 2022, IJMS CrossRef
71. Circulating plasma galectin-3 predicts new-onset atrial fibrillation in patients after acute myocardial infarction during hospitalization
    Qianhui Wang et al, 2022, BMC Cardiovasc Disord CrossRef
72. Current Advancements in Pectin: Extraction, Properties and Multifunctional Applications
    Vinay Chandel et al, 2022, Foods CrossRef
73. Potential Protective Role of Galectin-3 in Patients with Gonarthrosis and Diabetes Mellitus: A Cross-Sectional Study
    Jelena Milosevic et al, 2022, IJERPH CrossRef
74. Galectin-3 administration drives remyelination after hypoxic-ischemic induced perinatal white matter injury
    Qian Wang et al, 2022, Front. Cell. Neurosci. CrossRef
75. Macrophages, Chronic Inflammation, and Insulin Resistance
    He Li et al, 2022, Cells CrossRef
76. Single-cell RNA sequencing in atherosclerosis: Mechanism and precision medicine
    Qiaoyu Li et al, 2022, Front. Pharmacol. CrossRef
77. Practical Significance of Biomarkers in Axial Spondyloarthritis: Updates on Diagnosis, Disease Activity, and Prognosis
    Alexandra-Diana Diaconu et al, 2022, IJMS CrossRef
78. Exercise modulation in inflammation and metabolic hormonal disorders of COVID-19 to decrease risk factors in coronary heart disease
    Sahar Avazpour et al, 2022 CrossRef
79. Bad players in AL amyloidosis in the current era of treatment
    Natalia Kreiniz et al, 2023, Expert Review of Hematology CrossRef
80. A placenta-on-a-chip model to determine the regulation of FKBPL and galectin-3 in preeclampsia
    Sahar Masoumeh Ghorbanpour et al, 2023, Cell. Mol. Life Sci. CrossRef
81. Selection of target-binding proteins from the information of weakly enriched phage display libraries by deep sequencing and machine learning
    Tomoyuki Ito et al, 2023, mAbs CrossRef
82. CLINICAL VALUE OF GALECTIN-3 IN DIFFERENTIATING PAPILLARY THYROID CANCER FROM NODULAR GOITER
    Cătălina Poalelungi et al, 2022, Roum Arch Microbiol Immunol CrossRef
83. Galectin-3 and matrix metalloproteinases 2 and 9 in peripheral blood of gastric cancer patients
    Ekaterina A. Korotkova et al, 2023, Almanac of Clinical Medicine CrossRef
84. The potential roles of galectin-3 in AKI and CKD
    Fengyun Wang et al, 2023, Front. Physiol. CrossRef
85. Mesenchymal Stem Cells Ameliorate Fibrosis by Enhancing Autophagy via Inhibiting Galectin-3/Akt/mTOR Pathway and by Alleviating the EMT via Inhibiting Galectin-3/Akt/GSK3β/Snail Pathway in NRK-52E Fibrosis
    Yu Zhao et al, 2023, Int J Stem Cells CrossRef
86. Tip 2 Diabetes Mellitus’ lu hastalarda serum ve i̇drar galektin-3 düzeyi ile mikroalbuminüri arasındaki i̇lişkinin değerlendirilmesi
    Canan ERSOY et al, 2021 CrossRef
87. Galectin-3 in solid organ recipients: role in graft pathology and prospects for use
    D. A. Velikiy et al, 2023, RJTAO CrossRef